Skinvisible, Inc.
SKVI
$0.23
-$0.07-23.33%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 0.00% | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | 0.00% | 0.00% | |||
| SG&A Expenses | 60.24% | -13.23% | |||
| Depreciation & Amortization | -13.56% | 22.92% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 56.69% | -11.98% | |||
| Operating Income | -58.96% | 12.40% | |||
| Income Before Tax | 209.84% | 5.54% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 209.84% | 5.54% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 209.84% | 5.54% | |||
| EBIT | -58.96% | 12.40% | |||
| EBITDA | -62.77% | 13.71% | |||
| EPS Basic | 175.28% | 5.54% | |||
| Normalized Basic EPS | 8.61% | 5.50% | |||
| EPS Diluted | 173.22% | 9.86% | |||
| Normalized Diluted EPS | 8.61% | 3.42% | |||
| Average Basic Shares Outstanding | 45.95% | 0.00% | |||
| Average Diluted Shares Outstanding | 45.95% | -2.16% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||